Efficacy and Safety of Direct-Acting Antivirals in Hepatitis C Virus-Infected Patients Taking Proton Pump Inhibitors

被引：0
|
作者：
Wijarnpreecha, Karn [1 ]
Chesdachai, Supavit [2 ]
Thongprayoon, Charat [1 ]
Jaruvongvanich, Veeravich [3 ]
Ungprasert, Patompong [4 ]
Cheungpasitporn, Wisit [4 ]
机构：
[1] Bassett Med Ctr, Internal Med, Cooperstown, NY USA
[2] Mahidol Univ, Ramathibodi Hosp, Fac Med, Med, Bangkok, Thailand
[3] Univ Hawaii, Internal Med, Honolulu, HI 96822 USA
[4] Mayo Clin, Med, Rochester, MN USA
来源：
HEPATOLOGY | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1163
引用
收藏
页码：625A / 625A
页数：1
相关论文
共 50 条
  • [21] Editorial: ribavirin continues to play a role in treatment with direct-acting antivirals for hepatitis C virus-infected patients with decompensated cirrhosis
    Waldenstrom, J.
    Lagging, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (11-12) : 1115 - 1116
  • [22] Evaluation of the Safety Profile of Direct-Acting Antivirals on Patients with Hepatitis C Virus: A Pharmacovigilance Study
    Mai G. El-Marakby
    Mohamed H. Solayman
    Nagwa A. Sabri
    Therapeutic Innovation & Regulatory Science, 2023, 57 : 997 - 1007
  • [23] Risk of hepatocellular carcinoma and efficacy of direct-acting antivirals in patients with concurrent hepatitis C virus
    Harrod, Elizabeth
    Agarwal, Ritu
    Tabrizian, Parissa
    Rayapudi, Madhavi
    Ala, Aftab
    Fiel, Isabel
    Schwartz, Myron
    Dieterich, Douglas
    Friedman, Scott
    Saberi, Behnam
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E733 - E734
  • [24] Hepatitis C in HIV-Infected Patients: Impact of Direct-Acting Antivirals
    Kian Bichoupan
    Douglas T. Dieterich
    Drugs, 2014, 74 : 951 - 961
  • [25] Hepatitis C in HIV-Infected Patients: Impact of Direct-Acting Antivirals
    Bichoupan, Kian
    Dieterich, Douglas T.
    DRUGS, 2014, 74 (09) : 951 - 961
  • [26] Efficacy and safety of direct-acting antivirals for treatment-naive patients with genotype 1 hepatitis C virus infection
    Zhu, Xiaobo
    Wang, Mingqi
    Liu, Mei
    Yu, Xinghao
    Huang, Peng
    PERSONALIZED MEDICINE, 2019, 16 (05) : 421 - 429
  • [27] Evaluation of drug-drug interactions of direct-acting antivirals in hepatitis c virus infected patients
    Margusino-Framinan, L.
    Castro-Iglesias, A.
    Gimenez-Arufe, V.
    Fernandez-Oliveira, C.
    Cid-Silva, P.
    Mena-De-Cea, A.
    Rodriguez-Osorio, I.
    Pernas-Souto, B.
    Yanez-Martinez, M. D.
    Pertega-Diaz, S.
    Sanclaudio-Luhia, A.
    Martin-Herranz, I.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 311 - 311
  • [28] Improvement of Gut Diversity and Composition After Direct-Acting Antivirals in Hepatitis C Virus-Infected Patients With or Without Human Immunodeficiency Virus Coinfection
    Chuaypen, Natthaya
    Jinato, Thananya
    Avihingsanon, Anchalee
    Chirapongsathorn, Sakkarin
    Cheevadhanarak, Supapon
    Nookaew, Intawat
    Tanaka, Yasuhito
    Tangkijvanich, Pisit
    JOURNAL OF INFECTIOUS DISEASES, 2021, 224 (08): : 1410 - 1421
  • [29] The risk of hepatitis C virus recurrence in hepatitis C virus-infected patients treated with direct-acting antivirals after achieving a sustained virological response: A comprehensive analysis
    Huang, Peng
    Wang, Yan
    Yue, Ming
    Ge, Zhijun
    Xia, Xueshan
    Jeyarajan, Andre J.
    Holmes, Jacinta A.
    Yu, Rongbin
    Zhu, Chuanwu
    Yang, Sheng
    Lin, Wenyu
    Chung, Raymond T.
    LIVER INTERNATIONAL, 2021, 41 (10) : 2341 - 2357
  • [30] Safety of direct-acting antivirals in the treatment of chronic hepatitis C
    Ridruejo, Ezequiel
    EXPERT OPINION ON DRUG SAFETY, 2014, 13 (03) : 307 - 319
12345